This inventor holds 1 USPTO granted patent and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Pfizer Corporation. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Kevin Roger King: Innovator in Pharmaceutical Formulations
Introduction
Kevin Roger King is a notable inventor based in Chesterfield, MO (US). He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of stable liquid antibody formulations. His work is essential in advancing medical treatments and improving patient outcomes.
Latest Patents
Kevin holds a patent for a stable liquid antibody formulation. This invention relates to the field of pharmaceutical formulations of antibodies, specifically focusing on a stable liquid formulation and its pharmaceutical preparation and use. The patent exemplifies a liquid formulation of a humanized anti-NGF antibody, showcasing his innovative approach to enhancing the stability and efficacy of antibody treatments.
Career Highlights
Kevin is currently employed at Pfizer Corporation, a leading global biopharmaceutical company. His role at Pfizer allows him to work on cutting-edge research and development projects that aim to improve healthcare solutions. His expertise in antibody formulations positions him as a valuable asset to the company and the pharmaceutical industry.
Collaborations
Kevin collaborates with talented professionals in his field, including Advait Vijay Badkar and Leigh Kristen Bohack. These collaborations foster a creative environment that encourages innovation and the sharing of ideas, ultimately leading to advancements in pharmaceutical formulations.
Conclusion
Kevin Roger King is a distinguished inventor whose work in stable liquid antibody formulations is paving the way for new medical treatments. His contributions to Pfizer Corporation and the pharmaceutical industry highlight the importance of innovation in improving healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
